» Articles » PMID: 2723638

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 1989 Jun 1
PMID 2723638
Citations 303
Authors
Affiliations
Soon will be listed here.
Abstract

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease. There was no change in the total iron levels in any other region of the parkinsonian brain. Total copper levels were reduced by 34-45% in the substantia nigra in Parkinson's disease; no difference was found in the other brain areas examined. Zinc levels were increased in substantia nigra in Parkinson's disease by 50-54%, and the zinc content of the caudate nucleus and lateral putamen was also raised by 18-35%. Levels of manganese and lead were unchanged in all areas of the parkinsonian brain studied when compared to control brains, except for a small decrease (20%) in manganese content of the medial putamen. Increased levels of total iron in the substantia nigra may cause the excessive formation of toxic oxygen radicals, leading to dopamine cell death.

Citing Articles

Pulling back the mitochondria's iron curtain.

Ben Zichri-David S, Shkuri L, Ast T NPJ Metab Health Dis. 2025; 3(1):6.

PMID: 40052109 PMC: 11879881. DOI: 10.1038/s44324-024-00045-y.


Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


Hemochromatosis neural archetype reveals iron disruption in motor circuits.

Loughnan R, Ahern J, Boyle M, Jernigan T, Hagler Jr D, Iversen J Sci Adv. 2024; 10(47):eadp4431.

PMID: 39576859 PMC: 11584016. DOI: 10.1126/sciadv.adp4431.


L-Theanine Effectively Protects Against Copper-Facilitated Dopamine Oxidation: Implication for Relieving Dopamine Overflow-Associated Neurotoxicities.

Wang F, Huang X, Wang W, Li X, Hao M, Taylor E Mol Neurobiol. 2024; 62(4):4993-5005.

PMID: 39499422 DOI: 10.1007/s12035-024-04601-x.


Exenatide-Modified Deferoxamine-Based Nanoparticles Ameliorates Neurological Deficits in Parkinson's Disease Mice.

Huang Y, Wang X, Li W, Yue F, Wang M, Zhou F Int J Nanomedicine. 2024; 19:10401-10414.

PMID: 39430307 PMC: 11490209. DOI: 10.2147/IJN.S479670.